Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (11-20 of 303) with videos related to

Pageof 31
Sort By:
The Journal of Organic Chemistry|October 12, 2002
Micellar catalysis of Diels-Alder reactions: substrate positioning in the micelleTheo Rispens, Jan B F N Engberts
The Journal of Organic Chemistry|October 25, 2003
A kinetic study of 1,3-dipolar cycloadditions in micellar mediaTheo Rispens, Jan B F N Engberts
Therapeutic Drug Monitoring|March 23, 2017
Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological AgentsMarzia Caldano, William Raoul, Theo Rispens, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
The Ligands for Human IgG and Their Effector FunctionsSteven W de Taeye, Theo Rispens, Gestur Vidarsson
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 10, 2017
Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing"Zoé LE van Kempen, Theo Rispens, Joep Killestein
Journal of Immunological Methods|April 3, 2013
Preventing adsorption of immunoglobulin G to solid surfaces using poloxamer 407 eliminates artifactual stimulation of neutrophilsIwan Kustiawan, Ninotska I L Derksen, Theo Rispens
Journal of Pharmaceutical Sciences|November 22, 2011
Use of a human recombinant immunoglobulin G1 CH3 domain as a probe for detecting alternatively folded human IgG in intravenous Ig productsTheresa Guhr, Ninotska Derksen, Rob Aalberse, et al.
International Journal of Rheumatology|June 16, 2012
IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?Laura C Lighaam, Rob C Aalberse, Theo Rispens
Current Allergy and Asthma Reports|May 26, 2016
The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 ResponseRob C Aalberse, Thomas A Platts-Mills, Theo Rispens
Nature Reviews. Rheumatology|February 13, 2013
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritisPauline A van Schouwenburg, Theo Rispens, Gerrit Jan Wolbink
Pageof 31

Showing results (11-20 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Organic Chemistry|October 12, 2002
Micellar catalysis of Diels-Alder reactions: substrate positioning in the micelleTheo Rispens, Jan B F N Engberts
The Journal of Organic Chemistry|October 25, 2003
A kinetic study of 1,3-dipolar cycloadditions in micellar mediaTheo Rispens, Jan B F N Engberts
Therapeutic Drug Monitoring|March 23, 2017
Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological AgentsMarzia Caldano, William Raoul, Theo Rispens, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
The Ligands for Human IgG and Their Effector FunctionsSteven W de Taeye, Theo Rispens, Gestur Vidarsson
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 10, 2017
Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing"Zoé LE van Kempen, Theo Rispens, Joep Killestein
Journal of Immunological Methods|April 3, 2013
Preventing adsorption of immunoglobulin G to solid surfaces using poloxamer 407 eliminates artifactual stimulation of neutrophilsIwan Kustiawan, Ninotska I L Derksen, Theo Rispens
Journal of Pharmaceutical Sciences|November 22, 2011
Use of a human recombinant immunoglobulin G1 CH3 domain as a probe for detecting alternatively folded human IgG in intravenous Ig productsTheresa Guhr, Ninotska Derksen, Rob Aalberse, et al.
International Journal of Rheumatology|June 16, 2012
IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?Laura C Lighaam, Rob C Aalberse, Theo Rispens
Current Allergy and Asthma Reports|May 26, 2016
The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 ResponseRob C Aalberse, Thomas A Platts-Mills, Theo Rispens
Nature Reviews. Rheumatology|February 13, 2013
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritisPauline A van Schouwenburg, Theo Rispens, Gerrit Jan Wolbink
Pageof 31